Adenosine receptors and nucleoside transport sites in cardiac cells
- PMID: 1797306
- PMCID: PMC1908536
- DOI: 10.1111/j.1476-5381.1991.tb12442.x
Adenosine receptors and nucleoside transport sites in cardiac cells
Abstract
1. Potential mechanisms responsible for the prominent depression of atrioventricular conduction by adenosine have been investigated in guinea-pig heart. 2. Adenosine A1 receptors and nucleoside transport (NT) sites were identified and enumerated in cardiac myocytes, atrioventricular conduction cells and coronary endothelial cells in 10 microns sections by autoradiographical analysis of the binding of the A1 selective antagonist 8-cyclopentyl-1,3-[3H]-dipropylxanthine ([3H]-DPCPX) and the NT ligand [3H]-nitrobenzylthioinosine ([3H]-NBMPR), respectively. 3. Atrioventricular conduction cells were identified by acetylcholinesterase histochemistry and endothelial cells by von Willebrand factor immunohistochemistry. 4. Site-specific binding of [3H]-DPCPX, when expressed as grains per cell nucleus was significantly higher (30 fold) in conduction cells than in surrounding myocytes. [3H]-DPCPX site density on endothelial cells in adjacent coronary vessels was not significantly different from myocytes. 5. In contrast, autoradiography of [3H]-NBMPR sites in these areas indicated that, relative to myocytes, conduction cells and endothelial cells were significantly enriched (2 fold and 4.5 fold, respectively) in NT sites. 6. The pronounced dromotropic effect of adenosine in guinea-pig heart is correlated with a higher density of adenosine A1 receptors in atrioventricular conduction cells than in myocytes. The NT capacity of these cells, as estimated by [3H]-NBMPR binding site density, is not increased in proportion to A1 receptors.
Similar articles
-
Heterogeneity of nucleoside transport inhibitory sites in heart: a quantitative autoradiographical analysis.Br J Pharmacol. 1989 Jun;97(2):361-70. doi: 10.1111/j.1476-5381.1989.tb11962.x. Br J Pharmacol. 1989. PMID: 2788021 Free PMC article.
-
Subtypes of nucleoside transport inhibitory sites in heart: a quantitative autoradiographical analysis.Eur J Pharmacol. 1989 Apr 12;163(1):69-75. doi: 10.1016/0014-2999(89)90396-8. Eur J Pharmacol. 1989. PMID: 2744094
-
A novel irreversible antagonist of the A1-adenosine receptor.Mol Pharmacol. 1996 Jul;50(1):196-205. Mol Pharmacol. 1996. PMID: 8700113
-
Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.Br J Pharmacol. 1997 Nov;122(6):1202-8. doi: 10.1038/sj.bjp.0701465. Br J Pharmacol. 1997. PMID: 9401787 Free PMC article.
-
Nucleoside transport in guinea pig myocytes. Comparison of the affinities and transport velocities for adenosine and 2-chloroadenosine.Biochem Pharmacol. 1987 Apr 15;36(8):1275-80. doi: 10.1016/0006-2952(87)90081-5. Biochem Pharmacol. 1987. PMID: 3593414
Cited by
-
The antiarrhythmic effects of the nucleoside transporter inhibitor, R75231, in anaesthetized pigs.Br J Pharmacol. 1993 Jun;109(2):592-9. doi: 10.1111/j.1476-5381.1993.tb13612.x. Br J Pharmacol. 1993. PMID: 8358559 Free PMC article.
-
Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes.Mol Cell Biochem. 1998 Mar;180(1-2):193-9. Mol Cell Biochem. 1998. PMID: 9546646
-
Contribution of ENT4 to adenosine uptake in AC16 human cardiomyocytes under simulated ischemic conditions and its potential role in cardioprotection.Mol Biol Rep. 2022 Nov;49(11):11201-11208. doi: 10.1007/s11033-022-07902-3. Epub 2022 Sep 15. Mol Biol Rep. 2022. PMID: 36107375
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials